- Keine Daten
Deutsch
- English
- 简体中文
- 繁体中文
- Français
- Русский
- Italiano
- 日本語
- 한국어
- Português
- Deutsch
- Español
- Türkçe
- Ελληνικά
- Nederlands
- Tiếng Việt
- Polski
Recently, DustPhotonics released a single chip 800G-DR8 silicon photonic chip for data center applications, which is an important milestone in practical photonics in data centers. The company claims that its single-chip solution provides high-performance and easy to implement solutions for system architects.DustPhotonics' 800G-DR8 photonic integrated circuit provides a single chip solution for fib...
Makino Machine Tool Company, headquartered in Tokyo, Japan, and Fraunhofer Institute for Laser Technology (ILT), headquartered in Aachen, Germany, have collaborated to combine ultra-high speed laser material deposition (EHLA) and near net shape additive manufacturing (EHLA3D) with a five axis CNC platform. The new system developed can efficiently produce, coat, or repair complex geometric shapes o...
Recently, Confluence Networks LLC has announced a long-term partnership agreement with Laser Light Communications Inc., a developer and provider of software controlled optical network services.According to the agreement, Laser Light will adopt Confluence-1 submarine fiber optic network, which Confluence Networks is about to launch, as the core part of its global network. The protocol will last for...
Abstract: A groundbreaking discovery by CNR Nanotec and scientists from the University of Warsaw has revealed a robust method for creating long-lived quantum fluids using semiconductor photonic gratings. This study, published in the journal Nature Physics, marks a significant step forward in simulating complex systems through unique polariton droplets that demonstrate stability in lifespan and rec...
On July 3rd local time, Swiss ophthalmic care giant Alcon announced the acquisition of Israeli medical technology company Belkin Vision and its laser equipment assets for treating glaucoma.The transaction includes a prepayment of $81 million, of which approximately $65 million is in cash. In addition, if Alcon can establish this technology as the preferred first-line treatment option for clinical ...